| Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age (NCT04953884) | Octapharma | 2021-09-22 |
| Latin-American Von Willebrand Disease Registry (NCT04279717) | Academia Nacional de Medicina | 2020-02-01 |
| rVWF IN PROPHYLAXIS (NCT02973087) | Takeda | 2017-11-16 |
| A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) (NCT02932618) | Baxalta now part of Shire | 2017-11-06 |
| Molecular and Clinical Profile of Von Willebrand Disease in Spain (NCT02869074) | Spanish Society of Thrombosis and Haemostasis | 2017-10-03 |
| Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding (NCT02792205) | Nantes University Hospital | 2017-02-22 |
| The Effect of the Nutraceutical "Hemofix" on the Coagulation System (NCT01651468) | Hadassah Medical Organization | 2016-09-01 |
| Registry of Patients With Von WilLEbrand Disease Treated With Voncento® (NCT04657887) | CSL Behring | 2015-11-23 |
| Study of Voncento® in Subjects With Von Willebrand Disease (NCT02552576) | CSL Behring | 2015-10-05 |
| Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery (NCT02283268) | Baxalta now part of Shire | 2015-04-01 |
| Willebrand International Non-interventional Global Surveillance (NCT01949220) | Laboratoire français de Fractionnement et de Biotechnologies | 2014-03-01 |
| Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease (NCT02472665) | Grifols Therapeutics LLC | 2013-12-01 |
| Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador (NCT01589848) | Universidad del Azuay | 2013-03-01 |
| Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease (NCT01602419) | Octapharma | 2012-10-01 |
| Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) (NCT01410227) | Baxalta now part of Shire | 2011-11-01 |
| Extension Study of Biostate in Subjects With Von Willebrand Disease (NCT01224808) | CSL Behring | 2010-10-01 |
| Study of Biostate® in Children With Von Willebrand Disease (NCT01213446) | CSL Behring | 2010-08-01 |
| Evaluation of Menses in Congenital Bleeding Disorders (NCT01261936) | University of L'Aquila | 2010-02-01 |
| Efficacy and Safety of IL-11 in DDAVP Unresponsive (NCT00994929) | University of Pittsburgh | 2010-01-01 |
| Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease (NCT00941616) | CSL Behring | 2009-06-01 |
| Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease (NCT00816660) | Baxalta now part of Shire | 2008-12-01 |
| Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD) (NCT00630448) | Weill Medical College of Cornell University | 2008-11-01 |
| A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B (NCT00694785) | Archemix Corp. | 2008-10-01 |
| IL-11 in Adults With Von Willebrand Disease Undergoing Surgery (NCT00524225) | Margaret Ragni | 2008-02-01 |
| A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) (NCT00701545) | CSL Behring | 2008-02-01 |
| IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia (NCT00524342) | Margaret Ragni | 2008-01-01 |
| Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients (NCT00555555) | Grifols Biologicals, LLC | 2007-09-01 |
| National Study of Moderate and Severe Von Willebrand Disease in the Netherlands (NCT00510042) | Erasmus Medical Center | 2007-07-01 |
| The Von Willebrand Disease (VWD) International Prophylaxis Study (NCT00557908) | Skane University Hospital | 2007-06-01 |
| Optivate in People With Von Willebrand Disease Undergoing Surgery (NCT00404300) | Bio Products Laboratory | 2007-02-01 |
| A Study With OPTIVATE® in People With Von Willebrand Disease (NCT00387192) | Bio Products Laboratory | 2006-11-01 |
| Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle (NCT00178542) | The University of Texas Health Science Center, Houston | 2005-09-01 |
| Phase II Study of IL-11 (Neumega) in Von Willebrand Disease (NCT00151125) | University of Pittsburgh | 2004-07-01 |
| A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. (NCT02246881) | Bio Products Laboratory | 2001-10-01 |
| Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) (NCT00168090) | CSL Behring | 2001-10-01 |
| Treatment and Management of Women With Bleeding Disorders (NCT00111215) | Centers for Disease Control and Prevention | 2001-01-01 |